Kohlberg & Company acquire Nelipak® Healthcare Packaging


CRANSTON, R.I., July 02, 2019 (GLOBE NEWSWIRE) -- Nelipak® Corporation, Inc. (“Nelipak”), the leading provider of custom designed rigid packaging for the medical device and pharmaceutical industries, announced today that it has been acquired by Kohlberg & Company, L.L.C. (Kohlberg), a private equity firm headquartered in Mount Kisco, NY., from Mason Wells. The business will continue to operate under the name of Nelipak® Healthcare Packaging. 

Headquartered in Cranston, Rhode Island, Nelipak is the leading global manufacturer of custom-designed rigid healthcare packaging used for Class II and Class III medical devices, and pharma drug delivery products. The company operates strategically located cleanroom facilities meeting customers’ most stringent packaging requirements. Nelipaks’ experienced in-house design, development, prototyping, manufacturing and quality teams offer medical trays and blisters, surgical procedure trays, pharmaceutical handling trays, custom built sealing machines and other value-added services. With a staff of over 800, the company operates from seven production facilities, five in the Americas – located in Cranston, RI.; Whitehall, PA; Phoenix, AZ.; Humacao, Puerto Rico, San Jose, Costa Rica; two in Europe - located in Venray, the Netherlands and Galway, Ireland.

“We have accomplished a lot at Nelipak during the past six years, and we are very grateful for the support given to us by Mason Wells. Our future is very bright with Kohlberg,” said Mike Kelly, President and CEO of Nelipak. “Kohlberg is committed to investing in Nelipak to make us an even stronger organization with additional capabilities to offer our customers around the world. With our global locations, world class design team, modern cleanroom manufacturing, strong sales organization and experienced management team, Nelipak is well positioned to take advantage of growth opportunities in the market.”

“Nelipak has successfully transformed itself into a leading global player in healthcare packaging and an ideal platform for further industry consolidation,” commented Seth H. Hollander, Partner of Kohlberg. “Our plans include leveraging Mike and his team, and their customer relationships, with sizeable, global acquisitions.” Roger Prevot, Operating Partner of Kohlberg, added, “A business with Nelipak’s global market position represents a unique investment opportunity. We look forward to supporting Mike and his team as they continue to execute their plan for organic and M&A-driven growth, while continuing to provide their customers with best-in-class service.”

About Nelipak® Healthcare Packaging

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom thermoformed packaging products that provide superior protection for medical devices and pharmaceuticals. The company offers medical trays and blisters, surgical procedure trays, pharmaceutical handling trays, custom built sealing machines and other value-added services. Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world. With over 800 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Healthcare Packaging is a trade name of Nelipak Corporation

About Kohlberg & Company, LLC 

Kohlberg & Company, LLC (“Kohlberg”) is a leading private equity firm headquartered in Mount Kisco, New York. Since its inception in 1987, Kohlberg has organized eight private equity funds, through which it has raised over $7.5 billion of committed equity capital. Over its 32-year history, Kohlberg has completed 76 platform investments and nearly 200 add-on acquisitions, with an aggregate transaction value in excess of $15 billion. For more information, please visit

About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 202111.8.2020 17:00:10 CESTPress release

DUBLIN, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced today that it will report financial results for its first quarter of fiscal year 2021 on Tuesday, August 25, 2020. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at The news release will include summary financial information for the company’s first quarter of fiscal year 2021, which ended on Friday, July 31, 2020. Medtronic will host a webcast at 7:00 a.m. CDT to discuss financial results for its first quarter of fiscal year 2021. The webcast can be accessed at on August 25, 2020. Within 24 hours of the webcast, a replay and transcript of the prepared remarks will be available by clicking on the Investor Events link at Looking ahead, Medtronic plans to report its fiscal year 2021 second, third, and fourth quarter results on Tuesday, November 2

Saniona offentliggör prospekt avseende upptagande till handel av nyemitterade aktier på Nasdaq Stockholm11.8.2020 17:00:00 CESTPressemelding

PRESSMEDDELANDE EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, I ELLER TILL AUSTRALIEN, KANADA, HONGKONG, JAPAN, NYA ZEELAND, SINGAPORE, SYDAFRIKA, USA ELLER NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING SKULLE VARA OTILLÅTEN ELLER KRÄVA REGISTRERING ELLER ANNAN ÅTGÄRD ENLIGT TILLÄMPLIG LAG. 11 augusti, 2020 Styrelsen för Saniona AB (”Saniona”) har, med anledning av den riktade emission av aktier till ett antal amerikanska och internationella institutionella investerare och sektorspecialister som offentliggjordes den 10 augusti 2020 (den ”Riktade Emissionen”), upprättat ett prospekt inför upptagande till handel av de nya aktierna på Nasdaq Stockholm. Prospektet har idag godkänts och registrerats av Finansinspektionen och finns tillgängligt på Sanionas hemsida,, och kommer göras tillgängligt på Finansinspektionens hemsida, För mer information, vänligen kontakta Rami Levin, Koncernchef och

Saniona publishes prospectus regarding admission to trading of newly issued shares on Nasdaq Stockholm11.8.2020 17:00:00 CESTPress release

PRESS RELEASE NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE IN ACCORDANCE WITH APPLICABLE LAW. August 11, 2020 The Board of Directors of Saniona AB (”Saniona”) has, as a result of the directed issue of shares to a number of U.S. and international institutional investors and sector specialists that was published on August 10, 2020 (the “Directed Issue”), prepared a prospectus for admission to trading of the new shares on Nasdaq Stockholm. The prospectus has today been approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) and is now available on Saniona’s website,, and will be made available on the Swedish Financial Supervisory Authority’s website, For more

Cypress Development Announces 55% Increase in Lithium Mineral Resource at the Clayton Valley Lithium Project, Nevada11.8.2020 14:00:10 CESTPress release

VANCOUVER, British Columbia, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V:CYP) (OTCQB:CYDVF) (Frankfurt:C1Z1) (“Cypress” or “the Company”) is pleased to announce an updated Mineral Resource Estimate at the Company’s Clayton Valley Lithium Project in Nevada, USA. The work was completed by Global Resource Engineering located in Denver, Colorado. The updated Mineral Resource Estimate for the project utilizes the same economic and mining parameters found in the Company’s May 2020 Prefeasibility Study (PFS). The August 2020 Mineral Resource Estimate includes additional assay data from four drill holes received in June 2020 and was developed using the project’s entire contiguous property boundary. All resources are pit-constrained using property and/or geologic boundaries and are based on a cut-off grade of 900 ppm lithium (Li). Highlights of Mineral Resource Estimate Measured Resource Estimate increased to 574.1 million tonnes averaging 1,081 ppm Li or 3.3 million tonn

SpareBank 1 SMN: Strong customer growth and better-than-expected profit performance11.8.2020 13:00:00 CESTPress release

SpareBank 1 SMN recorded a post-tax profit of NOK 719m in the second quarter of 2020 compared with NOK 290m in the previous quarter. The second quarter brought higher growth, good financial earnings and lower losses. The group is gearing up to face sharp competition, lower economic growth and continued uncertainty about the corona pandemic. The post-tax profit for the first six months of the year was NOK 1,008m compared with NOK 1,729m in the same period of 2019. The subsidiaries EiendomsMegler 1 Midt-Norge, SpareBank 1 Regnskapshuset SMN, SpareBank 1 Finans Midt-Norge and SpareBank 1 Markets all show strong figures and account for an increasing share of the group’s earnings. “Central Norway recovered more rapidly than we could have expected in late winter. This is particularly evident in the housing market. It is also reflected in SpareBank 1 SMN’s accounts which show higher growth and lower losses than in the previous quarter. All credit to our customers and our staff for the way the

Kommuniké från extra bolagsstämma i Acarix11.8.2020 13:00:00 CESTPressemelding

Kommuniké från extra bolagsstämma i Acarix Extra bolagsstämma i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 11 augusti 2020 varvid aktieägarna fattade följande beslut. Godkännande av företrädesemission Extra bolagsstämman beslutade, i enlighet med styrelsens förslag, att godkänna den av styrelsen sedan tidigare beslutade företrädesemission avseende nyemission av högst 86 156 738 aktier med företrädesrätt för befintliga aktieägare. Genom företrädesemissionen kan aktiekapitalet öka med högst 861 567,38 kronor, till totalt 1 378 507,81 kronor, och antalet aktier och röster kan öka från 51 694 043 aktier och röster till maximalt 137 850 781 aktier och röster. Teckningskursen för aktierna är 0,65 kronor per aktie. Företrädesemissionen tillför Bolaget högst 56 001 879,70 kronor före transaktionskostnader om samtliga aktier tecknas. Teckning av aktier med stöd av teckningsrätter ska ske genom kontant betalning under tiden från och med den 21 augusti 2020 till och med den 4 september 2